{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:18:12Z","timestamp":1790338692914,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.08.043","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T18:01:50Z","timestamp":1543860110000},"page":"333-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model"],"prefix":"10.1016","volume":"37","author":[{"given":"Sarah","family":"Valencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennichi C.","family":"Dowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jason","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Lacayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.043_b0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.08.043_b0010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2016-07-723148","article-title":"In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia","volume":"129","author":"Francis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.08.043_b0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.043_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J Virol"},{"issue":"92","key":"10.1016\/j.vaccine.2018.08.043_b0025","article-title":"Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenitalcytomegalovirusinfections","volume":"2018","author":"Permar","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/rmv.645","article-title":"Human cytomegalovirus tropism for endothelial\/epithelial cells: scientific background and clinical implications","volume":"20","author":"Revello","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0035","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1128\/JVI.01325-15","article-title":"Human cytomegalovirus gH\/gL\/gO promotes the fusion step of entry into all cell types, whereas gH\/gL\/UL128-131 broadens virus tropism through a distinct mechanism","volume":"89","author":"Zhou","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0040","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1038\/ncomms9176","article-title":"Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody","volume":"6","author":"Chandramouli","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.08.043_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12026-012-8304-8","article-title":"Diverse immune evasion strategies by human cytomegalovirus","volume":"54","author":"Noriega","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2018.08.043_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/359869","article-title":"Human herpesviridae methods of natural killer cell evasion","volume":"2012","author":"Odom","year":"2012","journal-title":"Adv Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1711.2005.01412.x","article-title":"Insights into the mechanisms of CMV-mediated interference with cellular apoptosis","volume":"84","author":"Andoniou","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors","volume":"3","author":"Alcami","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.08.043_b0065","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jcv.2009.07.002","article-title":"Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant","volume":"46","author":"Pass","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.043_b0075","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.043_b0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.043_b0085","doi-asserted-by":"crossref","first-page":"362ra145","DOI":"10.1126\/scitranslmed.aaf9387","article-title":"A replication-defective human cytomegalovirus vaccine for prevention of congenital infection","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.08.043_b0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","article-title":"A phase 1 study of 4 live, recombinant human cytomegalovirus towne\/toledo chimera vaccines in cytomegalovirus-seronegative men","volume":"214","author":"Adler","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.043_b0095","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coviro.2017.08.005","article-title":"Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections","volume":"25","author":"Itell","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0105","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","article-title":"Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques","volume":"85","author":"Abel","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0110","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JVI.01970-10","article-title":"Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other","volume":"85","author":"Bowman","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0115","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1128\/JVI.79.9.5786-5798.2005","article-title":"Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11","volume":"79","author":"Pande","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000150","article-title":"Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus","volume":"4","author":"Powers","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.08.043_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.coi.2010.11.005","article-title":"Viral evasion of T cell immunity: ancient mechanisms offering new applications","volume":"23","author":"Horst","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2018.08.043_b0135","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2013.08.026","article-title":"Coding potential of UL\/b' from the initial source of rhesus cytomegalovirus Strain 68\u20131","volume":"447","author":"Gill","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.043_b0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.043_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002308","article-title":"Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge","volume":"7","author":"Sashihara","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.08.043_b0155","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00380-17","article-title":"Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells","volume":"91","author":"Mayer","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0160","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/JVI.01669-12","article-title":"A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques","volume":"87","author":"Wussow","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00430-008-0074-5","article-title":"Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques","volume":"197","author":"Yue","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0170","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0175","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006454-199201000-00006","article-title":"Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response","volume":"11","author":"White","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.08.043_b0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/infdis\/165.5.852","article-title":"Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine","volume":"165","author":"Sharp","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.043_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94002","article-title":"Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys","volume":"2","author":"Nelson","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2018.08.043_b0195","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1073\/pnas.1511526112","article-title":"Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission","volume":"112","author":"Bialas","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1006\/viro.1993.1323","article-title":"Analysis of the rhesus cytomegalovirus immediate-early gene promoter","volume":"194","author":"Alcendor","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.043_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virol.2007.10.040","article-title":"Protein coding content of the UL)b' region of wild-type rhesus cytomegalovirus","volume":"373","author":"Oxford","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.043_b0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2144\/01312st05","article-title":"Bifunctional protein conferring enhanced green fluorescence and puromycin resistance","volume":"31","author":"Abbate","year":"2001","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2018.08.043_b0215","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1099\/vir.0.19508-0","article-title":"Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques","volume":"84","author":"Yue","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.043_b0220","doi-asserted-by":"crossref","first-page":"19950","DOI":"10.1073\/pnas.0811063106","article-title":"Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types","volume":"105","author":"Lilja","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.08.043_b0225","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1128\/JVI.73.11.9576-9583.1999","article-title":"Pathogenesis of experimental rhesus cytomegalovirus infection","volume":"73","author":"Lockridge","year":"1999","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:00Z","timestamp":1759401000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18311721"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}